Tag - ablate

Feature

Actinium Pharma developing targeted conditioning for bone marrow transplant

By Len Zehr Actinium Pharmaceuticals (NYSE American:ATNM) intends to improve bone marrow transplants (BMT) access and patient outcomes and treat cancers with high unmet medical needs by combining the precision of...

September 11, 2018

Feature

Profound Medical’s TULSA-PRO pilot OUS launch: paving the way for global growth

By Len Zehr After nearly a decade of R&D, Profound Medical (OTCQX:PRFMF; TSXV:PRN) is now conducting a pilot launch of its TULSA-PRO medical device to ablate tissue in localized prostate cancer within key European...

March 28, 2017

Tag - ablate

Actinium Pharma developing targeted conditioning for bone marrow transplant

Profound Medical’s TULSA-PRO pilot OUS launch: paving the way for global growth

General

More